Aptamer developed by HKBU for treating rare bone disease 'X-linked hypophosphatemia' receives Orphan Drug Designation and Rare Pediatric Disease Designation by U.S. FDA


Aptamer developed by HKBU for treating rare bone disease 'X-linked hypophosphatemia' receives Orphan Drug Designation and Rare Pediatric Disease Designation by U.S. FDA

HONG KONG, Dec. 23, 2024 /PRNewswire/ -- A research led by Hong Kong Baptist University (HKBU) and the Shanghai Sixth People's Hospital Affiliated to School of Medicine at Shanghai Jiao Tong University (Shanghai Sixth People's Hospital) has discovered that an aptamer developed by HKBU can be used to treat X-linked hypophosphatemia (XLH), a rare bone disease. The aptamer, originally developed to treat osteogenesis imperfecta, has been granted Orphan Drug Designation and Pediatric Rare Disease Designation by the U.S. Food and Drug Administration (FDA).

XLH ("X" denotes X-chromosome, a sex-determining chromosome) is a rare bone disease characterised by hypophosphatemia (i.e., low phosphate in blood). It is caused by a mutation in the phosphate regulating endopeptidase homolog X-linked (PHEX) gene, and its inheritance pattern follows an X-linked dominant mode. The bone tissue of XLH patients cannot mineralise properly, thereby affecting the hardness of the bones. The cartilage between the ribs of children with XLH grows and connects like beads strung together. They also result in limb deformities and growth retardation. Adult patients experience symptoms such as osteomalacia, bone pain, changes in body shape, shorter stature and pseudo-fractures, leading to reduced mobility or even disability.

kAm!C@76DD@C +92?8 v6[ pDD@4:2E6 s62? W#6D62C49X @7 r9:?6D6 |65:4:?6 2?5 s:C64E@C @7 E96 {2H $2F u2: x?DE:EFE6 7@C p5G2?4:?8 %C2?D=2E:@?2= |65:4:?6 :? q@?6 2?5 y@:?E s:D62D6D 2E wzq&[ 2?5 !C@76DD@C +92?8 +96?=:?[ s:C64E@C @7 ~DE6@A@C@D:D 2?5 q@?6 s:D62D6D @7 E96 $92?892: $:IE9 !6@A=6VD w@DA:E2=[ 2=@?8 H:E9 pAE24FC6 %96C2A6FE:4D {E5][ 92G6 56G6=@A65 2 =@?8\24E:?8 D4=6C@DE:?\=@@Ab @=:8@?F4=6@E:56 2AE2>6C 7@C E96 EC62E>6?E @7 ){w] %9:D 2AE2>6C 92D 366? 8C2?E65 ~CA92? sCF8 s6D:8?2E:@? 2?5 !65:2EC:4 #2C6 s:D62D6 s6D:8?2E:@? 3J E96 &]$] usp 7@C EC62E>6?E @7 ){w 62C=:6C E9:D J62C]k^Am kAm#6D62C496CD 4@?5F4E65 D6CF> E6DED @? d' A2E:6?ED H:E9 ){w 7C@> E96 $92?892: $:IE9 !6@A=6VD w@DA:E2=] %96 C6DF=ED D9@H65 E92E E96:C D6CF> D4=6C@DE:? =6G6=D H6C6 2AAC@I:>2E6=J c]d E:>6D 9:896C E92? E9@D6 @7 962=E9J :?5:G:5F2=D @7 E96 D2>6 286 2?5 86?56C]k^AmkAm$4=6C@DE:? :D 2 AC@E6:? E92E :?9:3:ED 3@?6 8C@HE9 H9:=6 A=2J:?8 2 AC@E64E:G6 C@=6 :? E96 42C5:@G2D4F=2C DJDE6>] v6?6E:4 6G:56?46 D9@HD E92E D4=6C@DE:? 567:4:6?4J D:8?:7:42?E=J 6=6G2E6D D6CF> A9@DA9@CFD =6G6=D 2?5 :?4C62D6D 3@?6 >2DD :? >:46] w@H6G6C[ E96 >@?@4=@?2= D4=6C@DE:? 2?E:3@5J 4FCC6?E=J FD65 :?4C62D6D E96 C:D< @7 962CE 2EE24<D[ DEC@<6 2?5 42C5:@G2D4F=2C 5:D62D6D]k^AmkAm%96 C6D62C49 E62> 5:D4@G6C65 E92E D4=6C@DE:? :?9:3:ED 3@?6 7@C>2E:@? 2?5 AC@E64ED E96 42C5:@G2D4F=2C DJDE6> E9C@F89 5:776C6?E 5@>2:?D @7 E96 AC@E6:?] (96? D4=6C@DE:? =@D6D E96 Q=@@Ab 5@>2:?Q[ 3@?6 >2DD 2?5 DEC6?8E9 :?4C62D6[ 3FE :ED 42C5:@G2D4F=2C AC@E64E:G6 67764E C6>2:?D F?27764E65] %96 Q=@@Ab 5@>2:?Q @7 D4=6C@DE:? 42? E96C67@C6 D6CG6 2D 2 E96C2A6FE:4 >@=64F=2C E2C86E E@ AC@>@E6 3@?6 7@C>2E:@?[ H:E9 ?@ D276EJ 4@?46C? :? E96 42C5:@G2D4F=2C DJDE6>]k^Am kAm%96 C6D62C496CD E96? D4C66? @FE @=:8@?F4=6@E:56 2AE2>6CD pA4__' E92E 42? :?9:3:E E96 D4=6C@DE:? =@@Ab] p?:>2= 6IA6C:>6?ED D9@H65 E92E pA4__' 42? AC@>@E6 3@?6 7@C>2E:@? H:E9@FE :?4C62D:?8 42C5:@G2D4F=2C C:D<] xE 42? 2=D@ D:8?:7:42?E=J :?4C62D6 E96 3=@@5 A9@DA9@CFD =6G6=D @7 >:46 H:E9 ){w] %9:D :D 6IA64E65 E@ AC@G:56 2 5CF8 42?5:52E6 7@C E96 AC64:D6 EC62E>6?E @7 ){w A2E:6?ED]k^AmkAmp44@C5:?8 E@ E96 C68F=2E:@?D @7 E96 &]$] usp[ @?46 2 5CF8 F?56C 56G6=@A>6?E @3E2:?D ~CA92? sCF8 s6D:8?2E:@?[ :ED DF3D6BF6?E C6D62C49 2?5 56G6=@A>6?E >2J 2==@H 7@C 2 C65F4E:@? :? E96 ?F>36C @7 4=:?:42= EC:2= D2>A=6D[ 36 6I6>AE 7C@> ?6H 5CF8 >2C<6E:?8 2FE9@C:D2E:@? 766D[ 2?5 6?;@J D6G6? J62CD @7 >2C<6E 6I4=FD:G:EJ] !65:2EC:4 #2C6 s:D62D6 s6D:8?2E:@? 2==@HD 5CF8D E@ 36 C6G:6H65 H:E9 AC:@C:EJ] w2G:?8 366? 56D:8?2E65 2D 3@E9 2? @CA92? 5CF8 2?5 2 A65:2EC:4 C2C6 5:D62D6 3J E96 &]$] usp[ pA4__' 42? 2446=6C2E6 :ED 4=:?:42= EC2?D=2E:@? 2?5 :D 6IA64E65 E@ 36?67:E A2E:6?ED H:E9 ){w D@@?6C]k^AmkAmrFCC6?E=J[ E96 A:=@E D42=6 AC@5F4E:@? @7 pA4__' 92D 366? 4@>A=6E65 2?5 :D F?56C8@:?8 E96 AC64=:?:42= E@I:4@=@8:42= 2DD6DD>6?E 3J 2 E9:C5 A2CEJ] pA4__' :D D4965F=65 E@ 6?E6C 4=:?:42= EC:2=D :? 3@E9 |2:?=2?5 r9:?2 2?5 E96 &]$]k^AmkAm':6H @C:8:?2= 4@?E6?E E@ 5@H?=@25 >F=E:>65:2i k2 C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^2AE2>6C\56G6=@A65\3J\9<3F\7@C\EC62E:?8\C2C6\3@?6\5:D62D6\I\=:?<65\9JA@A9@DA92E6>:2\C646:G6D\@CA92?\5CF8\56D:8?2E:@?\2?5\C2C6\A65:2EC:4\5:D62D6\56D:8?2E:@?\3J\FD\752\b_abbg'eg]9E>=Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^2AE2>6C\56G6=@A65\3J\9<3F\7@C\EC62E:?8\C2C6\3@?6\5:D62D6\I\=:?<65\9JA@A9@DA92E6>:2\C646:G6D\@CA92?\5CF8\56D:8?2E:@?\2?5\C2C6\A65:2EC:4\5:D62D6\56D:8?2E:@?\3J\FD\752\b_abbg'eg]9E>=k^2mk^AmkAm$~&#rt w@?8 z@?8 q2AE:DE &?:G6CD:EJk^Am

Previous articleNext article

POPULAR CATEGORY

commerce

8882

tech

9850

amusement

10825

science

4918

various

11541

healthcare

8606

sports

11504